New Roads Open Up for Implementing Immunotherapy in Mesothelioma

Treatment options for malignant mesothelioma are limited, and the results with conventional therapies have been rather disappointing to this date. Chemotherapy is the only evidence-based treatment for mesothelioma patients in good clinical condition, with an increase in median survival of only 2 mon...

Descripción completa

Detalles Bibliográficos
Autores principales: Cornelissen, R., Heuvers, M. E., Maat, A. P., Hendriks, R. W., Hoogsteden, H. C., Aerts, J. G. J. V., Hegmans, J. P. J. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388483/
https://www.ncbi.nlm.nih.gov/pubmed/22778767
http://dx.doi.org/10.1155/2012/927240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388483/
https://www.ncbi.nlm.nih.gov/pubmed/22778767
http://dx.doi.org/10.1155/2012/927240

Ejemplares similares